Sight Sciences

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 2011-01-01

Employees: 214

Market Cap: -

Website: http://www.sightsciences.com

Introduction: Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive gla...

Clinical Trials

A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Pseudophakic Eyes

Phase 4

Not yet recruiting

Conditions: Primary Open Angle Glaucoma

Interventions: Device: OMNI Surgical System
Drug: Latanoprost plus adjunctive glaucoma medication

First Posted Date: 2024-05-09

Last Posted Date: 2024-05-22

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 334

Registration Number: NCT06407973

Locations: 🇺🇸
North Bay Eye Associates, Petaluma, California, United States
🇺🇸
University Eye Specialists, Maryville, Tennessee, United States

A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System

Completed

Conditions: Glaucoma, Open-Angle

Interventions: Device: OMNI® Surgical System

First Posted Date: 2021-09-16

Last Posted Date: 2024-01-17

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 72

Registration Number: NCT05044793

Locations: 🇺🇸
Grene Vision Group, Wichita, Kansas, United States
🇺🇸
Northern Ophthalmics, Jenkintown, Pennsylvania, United States
🇺🇸
Oklahoma Eye Surgeons, Oklahoma City, Oklahoma, United States

and more 1 locations

An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)

Completed

Conditions: Glaucoma, Open-Angle

Interventions: Device: OMNI® Surgical System

First Posted Date: 2021-05-04

Last Posted Date: 2024-01-17

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 28

Registration Number: NCT04872348

Locations: 🇺🇸
University Eye Specialists, Maryville, Tennessee, United States
🇺🇸
El Paso Eye Surgeons, El Paso, Texas, United States
🇺🇸
Virginia Eye Consultants, Norfolk, Virginia, United States

and more 7 locations

Prospective, Randomized, Masked, Controlled Trial To Evaluate The Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)

Not Applicable

Active, not recruiting

Conditions: Dry Eye
Meibomian Gland Dysfunction

Interventions: Device: TearCare System
Drug: Restasis

First Posted Date: 2021-03-12

Last Posted Date: 2022-09-13

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 350

Registration Number: NCT04795752

Locations: 🇺🇸
Harvard Eye Associates, Laguna Hills, California, United States
🇺🇸
Eye Research Foundation, Newport Beach, California, United States
🇺🇸
Doctor My Eyes, Scottsdale, Arizona, United States

and more 11 locations

Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)

Not Applicable

Terminated

Conditions: Glaucoma, Open-Angle

Interventions: Device: OMNI® Surgical System
Device: iStent inject

First Posted Date: 2020-12-08

Last Posted Date: 2022-08-31

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 20

Registration Number: NCT04658095

Locations: 🇪🇸
Universidad Complutense de Madrid, Valencia, Spain
🇪🇸
Paseo Isabel la Católica 1-3. Edificio general Hospital Miguel Servet. Planta calle, Zaragoza, Spain
🇩🇪
BurgerHospital, Frankfurt, Germany

and more 2 locations

A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma

Not Applicable

Terminated

Conditions: Glaucoma, Open-Angle

Interventions: Device: iStent inject
Device: OMNI® Surgical System

First Posted Date: 2020-11-05

Last Posted Date: 2022-12-01

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 1

Registration Number: NCT04616573

Locations: 🇺🇸
Eye Associates and SurgiCenter of Vineland, Vineland, New Jersey, United States
🇺🇸
Eye Center South, Dothan, Alabama, United States

A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma

Not Applicable

Terminated

Conditions: Glaucoma, Open-Angle

Interventions: Device: OMNI® Surgical System

First Posted Date: 2020-07-10

Last Posted Date: 2022-06-28

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 78

Registration Number: NCT04465630

Locations: 🇺🇸
Assil Eye Institute, Santa Monica, California, United States
🇺🇸
Utah Eye Centers, Ogden, Utah, United States
🇺🇸
Vold Vision, Fayetteville, Arkansas, United States

and more 8 locations

Study of OMNI System in OAG (GEMINI)

Not Applicable

Completed

Conditions: Open Angle Glaucoma

Interventions: Device: Transluminal viscoelastic delivery and trabeculotomy

First Posted Date: 2019-03-04

Last Posted Date: 2024-08-14

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 209

Registration Number: NCT03861169

Locations: 🇺🇸
Vold Vision, Fayetteville, Arkansas, United States
🇺🇸
Eye Center South, Dothan, Alabama, United States
🇺🇸
Eye Physicians and Surgeons, LLP, Iowa City, Iowa, United States

and more 12 locations

TearCare System to Treat Dry Eye Disease

Not Applicable

Recruiting

Conditions: Meibomian Gland Dysfunction
Dry Eye

Interventions: Device: LipiFlow
Device: TearCare

First Posted Date: 2019-02-28

Last Posted Date: 2019-09-18

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 138

Registration Number: NCT03857919

Locations: 🇺🇸
Center for Excellence in Eye Care, Miami, Florida, United States

Pilot Study of TearCare System - Long-Term Extension

Not Applicable

Conditions: Dry Eye Syndromes

Interventions: Device: TearCare

First Posted Date: 2019-01-15

Last Posted Date: 2019-01-15

Lead Sponsor: Sight Sciences, Inc.

Target Recruit Count: 8

Registration Number: NCT03804502

Locations: 🇺🇸
Central Eye Care, Arlington Heights, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy